Company Filing History:
2 out of 15,528 
1 out of 3,224 
1 out of 276 
Years Active: 1999-2006
Title: Hal V Barron: Innovator in Thrombolytic Treatment
Introduction
Hal V Barron is a notable inventor based in San Francisco, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of thrombolytic disorders. With a total of 3 patents, his work has had a profound impact on therapeutic regimens.
Latest Patents
One of his latest patents is titled "Combination treatment with t-PA variant and low molecular weight heparin." This invention focuses on an improved therapeutic regimen for treating thrombolytic disorders, such as acute myocardial infarction (AMI). The invention involves a tissue plasminogen activator (t-PA) variant that has enhanced fibrin specificity and an extended plasma half-life compared to wild-type human t-PA, combined with low molecular weight heparin.
Another significant patent is "Method for treating occlusive peripheral vascular disease and coronary disease." This patent discloses compositions and methods for treating occlusive peripheral vascular disease and coronary disease. The methods promote the growth of new blood vessels, known as angiogenesis, and involve the co-administration of an adenosine A receptor agonist, such as adenosine, along with heparin or a heparin-like substance over several days. This invention is particularly applicable for improving collateral coronary circulation in patients suffering from myocardial infarction.
Career Highlights
Hal V Barron has worked with prestigious organizations, including the University of California and Genentech, Inc. His experience in these institutions has allowed him to develop innovative solutions in the medical field.
Collaborations
Throughout his career, Hal has collaborated with notable individuals such as Elias Botvinick and Paul Armstrong. These collaborations have contributed to the advancement of his research and inventions.
Conclusion
Hal V Barron is a distinguished inventor whose work in thrombolytic treatment has led to significant advancements in medical therapies. His innovative patents and collaborations highlight his commitment to improving patient outcomes.